Article
Origins, genetic landscape, and emerging therapies of small cell lung cancer.
Genes & development - 15 Jul 2015
Semenova Ekaterina A, Nagel Remco, Berns Anton
Abstract excerpt
Lung cancer is the leading cause of cancer deaths, with small cell lung cancer (SCLC) representing the most aggressive subtype. Standard treatments have not changed in decades, and the 5-year survival rate has remained <7%. Genomic analyses have identified key driver mutations of SCLC that were subsequently validated in animal models of SCLC. To provide better treatment options, a deeper understanding of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
